These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine. Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014 [TBL] [Abstract][Full Text] [Related]
9. Aspirin and the prevention of colorectal cancer. Ferrández A; Piazuelo E; Castells A Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156 [TBL] [Abstract][Full Text] [Related]
11. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome. Tuccori M; Filion KB; Azoulay L J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870 [No Abstract] [Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. Hawk ET; Viner J; Richmond E; Umar A Cancer Chemother Biol Response Modif; 2003; 21():759-89. PubMed ID: 15338773 [No Abstract] [Full Text] [Related]
13. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533 [TBL] [Abstract][Full Text] [Related]
14. Response. Ait Ouakrim D; Dashti SG; Win AK J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711871 [No Abstract] [Full Text] [Related]
15. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217 [TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention. Sangha S; Yao M; Wolfe MM Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention in hereditary colorectal cancer syndromes. Hawk E; Lubet R; Limburg P Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181 [TBL] [Abstract][Full Text] [Related]
18. Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression. Wood NJ; Quinton NA; Burdall S; Sheridan E; Duffy SR Int J Gynecol Cancer; 2007; 17(2):447-54. PubMed ID: 17316360 [TBL] [Abstract][Full Text] [Related]
19. [Aspirin in the primary prevention of colorectal cancer]. Fernández Calderón M; Betés Ibáñez MT An Sist Sanit Navar; 2012; 35(2):261-7. PubMed ID: 22948427 [TBL] [Abstract][Full Text] [Related]
20. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis]. Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]